Literature DB >> 20097771

Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction.

Kyle T Keyes1, Jing Xu, Bo Long, Congfang Zhang, Zhaoyong Hu, Yumei Ye.   

Abstract

Phosphoinositide 3-kinase (PI3K) mediates myocardium protective signaling through phosphorylation of phosphatidylinositol (Ptdins) to produce Ptdins(3,4,5)P(3). Lipid phosphatase and tensin homolog on chromosome 10 (PTEN) antagonizes PI3K activity by dephosphorylating Ptdins(3,4,5)P(3); therefore, the inhibition of PTEN enhances PI3K/Akt signaling and could prevent myocardium from ischemia-reperfusion (I/R) injury. Here we studied 1) whether the pharmacological inhibition of PTEN by bisperoxovanadium molecules [BpV(HOpic)] attenuates simulated I/R (SIR) injury in vitro and 2) whether the administration of BpV(HOpic) either before or after ischemia limits myocardial infarct size (IS) and ameliorates cardiodysfunction caused by infarction. First, adult rat cardiomyocytes were treated with or without BpV(HOpic) and then exposure to SIR. Second, anesthetized rats received BpV(HOpic) either before or after ischemia. IS was assessed at 4 h reperfusion, and left ventricular function was evaluated by echocardiography at 28 days postreperfusion. As a result, BpV(HOpic) decreased cell death, improved 3-[4,5-yl]-2,5-diphenyltetrazolium bromide (MTT) viability, and reduced apoptosis in cells exposed to SIR. These protective effects of BpV(HOpic) are associated with increased phospho-Akt and the repression of caspase-3 activity. Second, the administration of BpV(HOpic) significantly reduced IS and suppressed caspase-3 activity following I/R injury and consequentially improved cardiac function at 28 day postinfarction. These beneficial effects of BpV(HOpic) are attributed to increases in myocardial levels of phosphorylation of Akt/endothelial nitric oxide synthase (eNOS), ERK-1/2, and calcium-dependent nitric oxide synthase activity. In conclusion, the pharmacological inhibition of PTEN protects against I/R injury through the upregulation of the PI3K/Akt/eNOS/ERK prosurvival pathway, suggesting a new therapeutic strategy to combat I/R injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20097771     DOI: 10.1152/ajpheart.00915.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  44 in total

1.  Phosphatase PTEN is critically involved in post-myocardial infarction remodeling through the Akt/interleukin-10 signaling pathway.

Authors:  Nirmal Parajuli; Yuan Yuan; Xiaoxu Zheng; Djahida Bedja; Zheqing P Cai
Journal:  Basic Res Cardiol       Date:  2012-02-02       Impact factor: 17.165

2.  Role of PTEN in modulation of ADP-dependent signaling pathways in vascular endothelial cells.

Authors:  Rosa Bretón-Romero; Hermann Kalwa; Santiago Lamas; Thomas Michel
Journal:  Biochim Biophys Acta       Date:  2013-06-25

3.  PTEN inhibitor VO-OHpic attenuates inflammatory M1 macrophages and cardiac remodeling in doxorubicin-induced cardiomyopathy.

Authors:  Taylor A Johnson; Dinender K Singla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-10       Impact factor: 4.733

Review 4.  Modulation of VEGF receptor 2 signaling by protein phosphatases.

Authors:  Federico Corti; Michael Simons
Journal:  Pharmacol Res       Date:  2016-11-23       Impact factor: 7.658

5.  Myocardial ischemic post-conditioning attenuates ischemia reperfusion injury via PTEN/Akt signal pathway.

Authors:  Chun-Mei Li; Shu-Wen Shen; Tao Wang; Xing-Hua Zhang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

6.  Cardioprotection by ischemic postconditioning is abolished in depressed rats: role of Akt and signal transducer and activator of transcription-3.

Authors:  Chuanjun Zhuo; Ying Wang; Xiaohui Wang; Yufen Wang; Yuhui Chen
Journal:  Mol Cell Biochem       Date:  2010-09-10       Impact factor: 3.396

7.  MicroRNA-1 transfected embryonic stem cells enhance cardiac myocyte differentiation and inhibit apoptosis by modulating the PTEN/Akt pathway in the infarcted heart.

Authors:  Carley Glass; Dinender K Singla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-08-19       Impact factor: 4.733

8.  A novel pharmacological strategy by PTEN inhibition for improving metabolic resuscitation and survival after mouse cardiac arrest.

Authors:  Jing Li; Huashan Wang; Qiang Zhong; Xiangdong Zhu; Sy-Jou Chen; Yuanyu Qian; Jim Costakis; Gabrielle Bunney; David G Beiser; Alan R Leff; E Douglas Lewandowski; J Michael ÓDonnell; Terry L Vanden Hoek
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-20       Impact factor: 4.733

9.  Myeloid PTEN deficiency protects livers from ischemia reperfusion injury by facilitating M2 macrophage differentiation.

Authors:  Shi Yue; Jianhua Rao; Jianjun Zhu; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Ling Lu; Xuehao Wang; Yuan Zhai
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

10.  Redox-sensitive oxidation and phosphorylation of PTEN contribute to enhanced activation of PI3K/Akt signaling in rostral ventrolateral medulla and neurogenic hypertension in spontaneously hypertensive rats.

Authors:  Kay L H Wu; Chiung-Ai Wu; Chih-Wei Wu; Samuel H H Chan; Alice Y W Chang; Julie Y H Chan
Journal:  Antioxid Redox Signal       Date:  2012-08-16       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.